The McLean Hospital Corporation

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

An Open-Label Trial of Duloxetine for the Treatment of Irritable Bowel Syndrome

Phase 4

Completed

Conditions: Irritable Bowel Syndrome

Interventions: Drug: duloxetine

First Posted Date: 2006-11-20

Last Posted Date: 2018-03-09

Lead Sponsor: Mclean Hospital

Target Recruit Count: 15

Registration Number: NCT00401258

Locations: 🇺🇸
McLean Hospital, Belmont, Massachusetts, United States

An Open-Label Trial of Memantine in the Treatment of Binge Eating Disorder

Phase 4

Completed

Conditions: Binge Eating Disorder

First Posted Date: 2006-05-29

Last Posted Date: 2007-08-14

Lead Sponsor: Mclean Hospital

Target Recruit Count: 15

Registration Number: NCT00330655

Locations: 🇺🇸
McLean Hospital, Belmont, Massachusetts, United States

Prescription Opioid Addiction Treatment Study (POATS)

Phase 3

Completed

Conditions: Opiate Dependence
Substance-related Disorders
Opioid-related Disorders

Interventions: Behavioral: Enhanced Medical Management (EMM) of Prescription Opiate Abuse
Behavioral: Standard Medical Management (SMM) of Prescription Opiate Abuse

First Posted Date: 2006-04-20

Last Posted Date: 2013-02-06

Lead Sponsor: Mclean Hospital

Target Recruit Count: 653

Registration Number: NCT00316277

Locations: 🇺🇸
East Indiana Treatment Center, Lawrenceburg, Indiana, United States
🇺🇸
North Shore - Long Island Jewish Health Systems, Glen Oaks, New York, United States
🇺🇸
McLean Hospital, Alcohol and Drug Abuse Treatment Program, Belmont, Massachusetts, United States

and more 9 locations

AndroGel in Men With Major Depression and Incomplete Response to Antidepressant Treatment

Phase 4

Completed

Conditions: Depressive Disorder, Major

Interventions: Drug: Testosterone gel
Drug: Placebo

First Posted Date: 2006-03-20

Last Posted Date: 2010-11-24

Lead Sponsor: Mclean Hospital

Target Recruit Count: 100

Registration Number: NCT00304746

Locations: 🇺🇸
McLean Hospital, Belmont, Massachusetts, United States
🇮🇱
The Chaim Sheba Medical Center, Tel-Hashomer, Israel

Magnetic Resonance Imaging Study of Geriatric Depression

Not Applicable

Completed

Conditions: Major Depressive Disorder

Interventions: Drug: Sertraline

First Posted Date: 2005-10-28

Last Posted Date: 2017-03-30

Lead Sponsor: Mclean Hospital

Target Recruit Count: 43

Registration Number: NCT00245557

Locations: 🇺🇸
McLean Hospital, Belmont, Massachusetts, United States

The Women's Recovery Group Study: Stage I Trial

Phase 1

Completed

Conditions: Alcohol-Related Disorders
Substance-Related Disorders

Interventions: Behavioral: The Women's Recovery Group
Behavioral: mixed-gender Group Drug Counseling

First Posted Date: 2005-09-30

Last Posted Date: 2023-11-01

Lead Sponsor: Mclean Hospital

Target Recruit Count: 46

Registration Number: NCT00230100

Locations: 🇺🇸
McLean Hospital, Belmont, Massachusetts, United States

Low Field Magnetic Stimulation Treatment for Bipolar Depression

Phase 3

Terminated

Conditions: Bipolar Depression
Bipolar Disorder
Depression

Interventions: Device: Echo-Planar Magnetic Resonance Imaging (EP-MRSI)

First Posted Date: 2005-09-22

Last Posted Date: 2012-03-14

Lead Sponsor: Mclean Hospital

Target Recruit Count: 13

Registration Number: NCT00217217

Locations: 🇺🇸
McLean Hospital, Belmont, Massachusetts, United States

Taurine as an Anti-Manic Agent: A Double-Blind, Placebo-Controlled Study

Phase 2

Completed

Conditions: Mania
Bipolar Disorder
Bipolar Depression

Interventions: Drug: taurine

First Posted Date: 2005-09-22

Last Posted Date: 2019-03-01

Lead Sponsor: Mclean Hospital

Target Recruit Count: 60

Registration Number: NCT00217165

Locations: 🇺🇸
McLean Hospital, Belmont, Massachusetts, United States

Understanding Brain Reward Responses in Individuals With Major Depressive Disorder

Completed

Conditions: Depression

First Posted Date: 2005-09-16

Last Posted Date: 2014-04-21

Lead Sponsor: Mclean Hospital

Target Recruit Count: 87

Registration Number: NCT00183755

Locations: 🇺🇸
Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Charlestown, Massachusetts, United States
🇺🇸
The Depression Clinical and Research Program, Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
Affective Neuroscience Laboratory, Department of Psychology, Harvard University, Cambridge, Massachusetts, United States

Effects of Citicoline on Brain Function and Behavior in Marijuana-Dependent Individuals

Phase 2

Completed

Conditions: Marijuana Abuse

Interventions: Drug: citicoline
Drug: placebo

First Posted Date: 2005-09-12

Last Posted Date: 2014-10-22

Lead Sponsor: Mclean Hospital

Target Recruit Count: 21

Registration Number: NCT00158249

Locations: 🇺🇸
McLean Hospital, Department of Psychiatry, Belmont, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy